SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-007829
Filing Date
2017-10-31
Accepted
2017-10-31 16:31:42
Documents
57
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bpmc-20170930x10q.htm 10-Q 1590156
2 EX-10.1 bpmc-20170930ex101a9a4c6.htm EX-10.1 99335
3 EX-31.1 bpmc-20170930ex311d03a68.htm EX-31.1 17836
4 EX-31.2 bpmc-20170930ex312bd4077.htm EX-31.2 17891
5 EX-32.1 bpmc-20170930ex321430d76.htm EX-32.1 13907
  Complete submission text file 0001558370-17-007829.txt   5452623

Data Files

Seq Description Document Type Size
6 EX-101.INS bpmc-20170930.xml EX-101.INS 990306
7 EX-101.SCH bpmc-20170930.xsd EX-101.SCH 42105
8 EX-101.CAL bpmc-20170930_cal.xml EX-101.CAL 37429
9 EX-101.DEF bpmc-20170930_def.xml EX-101.DEF 159240
10 EX-101.LAB bpmc-20170930_lab.xml EX-101.LAB 417638
11 EX-101.PRE bpmc-20170930_pre.xml EX-101.PRE 293986
Mailing Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139
Business Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37359 | Film No.: 171166093
SIC: 2834 Pharmaceutical Preparations